These TNF-α cytokine networks help explain further the observation that anti-TNFα mAb treatment in RA patients with LTBI leads to dysfunction of CD8+ T cells or other T effectors, with consequence of reactivation of tuberculosis (46). This evidence concerns the gene CD8A and tuberculosis.